| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8279412 | Journal of the Neurological Sciences | 2013 | 8 Pages |
Abstract
The present data suggest that an EPO application in a timely distance to the SAH is sufficient to prevent delayed proximal CVS, but that the doses were insufficient to improve microcirculation or to be directly neuroprotective.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Erdem Güresir, Nikos Vasiliadis, Jürgen Konczalla, Peter Raab, Elke Hattingen, Volker Seifert, Hartmut Vatter,